Apyx Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Apyx Medical
APYX Stock  USD 1.07  0.06  5.31%   
Apyx Medical financial statements provide useful quarterly and yearly information to potential Apyx Medical investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Apyx Medical financial statements helps investors assess Apyx Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Apyx Medical's valuation are summarized below:
Gross Profit
29.4 M
Profit Margin
(0.49)
Market Capitalization
42.5 M
Enterprise Value Revenue
0.9909
Revenue
48.1 M
We have found one hundred twenty available fundamental signals for Apyx Medical, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Apyx Medical prevailing market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 66.7 M in 2025. Enterprise Value is likely to drop to about 66.4 M in 2025

Apyx Medical Total Revenue

27.12 Million

Check Apyx Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Apyx Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 736.2 K, Selling General Administrative of 45.3 M or Total Revenue of 27.1 M, as well as many indicators such as Price To Sales Ratio of 1.11, Dividend Yield of 0.0 or PTB Ratio of 3.75. Apyx financial statements analysis is a perfect complement when working with Apyx Medical Valuation or Volatility modules.
  
Check out the analysis of Apyx Medical Correlation against competitors.
For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.

Apyx Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets34.2 M64.8 M48 M
Slightly volatile
Short and Long Term Debt Total4.1 M4.9 M5.9 M
Pretty Stable
Other Current Liabilities8.1 M7.8 M4.9 M
Slightly volatile
Total Current Liabilities11.3 M10.7 M7.4 M
Slightly volatile
Total Stockholder Equity24.1 M14.2 M32.6 M
Slightly volatile
Property Plant And Equipment Net5.4 M6.7 M6.5 M
Slightly volatile
Accounts Payable1.3 M2.6 M1.7 M
Slightly volatile
Cash33.3 M31.7 M20.4 M
Slightly volatile
Non Current Assets Total8.3 M8.4 M8.7 M
Pretty Stable
Cash And Short Term Investments33.3 M31.7 M24.2 M
Slightly volatile
Net Receivables16.3 M15.5 M8.7 M
Slightly volatile
Good Will144.8 K212.8 K190.4 K
Slightly volatile
Common Stock Total Equity24.1 K31.5 K30.6 K
Very volatile
Common Stock Shares Outstanding22.9 M35.5 M26.7 M
Slightly volatile
Liabilities And Stockholders Equity34.2 M64.8 M48 M
Slightly volatile
Non Current Liabilities Total41.8 M39.8 M10.7 M
Slightly volatile
Inventory5.4 M7.6 M6.6 M
Slightly volatile
Other Current Assets1.1 M1.7 M1.4 M
Slightly volatile
Other Stockholder Equity96.7 M92.1 M55.8 M
Slightly volatile
Total Liabilities53 M50.5 M18 M
Slightly volatile
Property Plant And Equipment Gross5.6 M10.7 M7 M
Slightly volatile
Total Current Assets59.3 M56.4 M41.4 M
Slightly volatile
Short Term Debt322.6 K355 K357.7 K
Slightly volatile
Intangible Assets6.6 K6.9 K877.7 K
Slightly volatile
Common Stock24.4 K38 K31 K
Very volatile
Other Assets1.1 M1.4 M1.3 M
Pretty Stable
Property Plant Equipment5.8 M7.8 M6.4 M
Slightly volatile
Long Term Debt35.6 M33.9 M17.3 M
Slightly volatile
Other Liabilities1.8 M1.8 M2 M
Pretty Stable
Net Tangible Assets40.5 M43.2 M36.5 M
Slightly volatile
Long Term Debt Total360 K378.9 K2.9 M
Slightly volatile
Capital Surpluse51.5 M84.3 M49.7 M
Slightly volatile
Deferred Long Term Asset Charges21.4 K22.5 K532.7 K
Slightly volatile
Warrants3 M3.7 M3 M
Slightly volatile
Preferred Stock Total Equity855900764.9 K
Slightly volatile
Deferred Long Term Liabilities467.6 K349.2 K489.4 K
Slightly volatile
Short and Long Term Debt175.4 K126 K190.8 K
Slightly volatile
Net Invested Capital44.7 M48.1 M41.6 M
Slightly volatile
Net Working Capital40.2 M45.7 M34.9 M
Slightly volatile
Capital Stock38.3 K38 K34.6 K
Slightly volatile
Capital Lease Obligations5.1 M4.9 M1.7 M
Slightly volatile
Noncontrolling Interest In Consolidated Entity239.8 K242.7 K170.5 K
Slightly volatile

Apyx Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization736.2 K795.8 K780.1 K
Pretty Stable
Selling General Administrative45.3 M43.1 M26.3 M
Slightly volatile
Total Revenue27.1 M48.1 M31.8 M
Slightly volatile
Gross Profit30.8 M29.4 M18.6 M
Slightly volatile
Other Operating Expenses31.7 M48.2 M40.3 M
Slightly volatile
Research Development5.3 M5.1 M2.9 M
Slightly volatile
Cost Of Revenue13.4 M18.7 M14.3 M
Pretty Stable
Total Operating Expenses18.4 M29.5 M26 M
Slightly volatile
Selling And Marketing Expenses23.7 M22.6 M7.8 M
Slightly volatile
Interest Income1.7 M1.6 M1 M
Slightly volatile
Discontinued Operations88.8 M84.5 M42.3 M
Slightly volatile
Extraordinary Items88.8 M84.5 M42.3 M
Slightly volatile
Reconciled Depreciation844.2 K599 K741 K
Slightly volatile

Apyx Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow45.8 M43.7 M19.5 M
Slightly volatile
Depreciation724.3 K599 K751 K
Pretty Stable
Capital Expenditures906.1 K722 K646.6 K
Slightly volatile
End Period Cash Flow33.3 M31.7 M20.4 M
Slightly volatile
Stock Based Compensation4.2 M4 M2.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.111.16745.3074
Pretty Stable
PTB Ratio3.753.951910.1663
Slightly volatile
Days Sales Outstanding12311787.8295
Slightly volatile
Book Value Per Share0.740.40331.1216
Pretty Stable
Average Payables557.5 K956.1 K983.2 K
Very volatile
Stock Based Compensation To Revenue0.04650.08340.0606
Slightly volatile
Capex To Depreciation1.391.20530.9404
Very volatile
PB Ratio3.753.951910.1663
Slightly volatile
EV To Sales0.580.60884.836
Pretty Stable
Inventory Turnover3.272.47782.4692
Slightly volatile
Days Of Inventory On Hand116147170
Pretty Stable
Payables Turnover13.327.16719.6408
Slightly volatile
Sales General And Administrative To Revenue0.570.840.7325
Slightly volatile
Average Inventory3.8 M3.7 M3.8 M
Slightly volatile
Research And Ddevelopement To Revenue0.110.10560.0846
Slightly volatile
Capex To Revenue0.01430.0150.0229
Slightly volatile
Cash Per Share0.940.89310.7724
Slightly volatile
Days Payables Outstanding31.5950.927149.6645
Pretty Stable
Intangibles To Total Assets0.00220.00230.0403
Slightly volatile
Current Ratio3.825.26445.5534
Very volatile
Receivables Turnover2.953.10746.4771
Slightly volatile
Shareholders Equity Per Share0.740.39981.1198
Pretty Stable
Debt To Equity0.290.34280.3565
Pretty Stable
Capex Per Share0.01930.02030.0278
Slightly volatile
Average Receivables2.6 M2.5 M2.6 M
Slightly volatile
Revenue Per Share0.981.35341.2296
Slightly volatile
Debt To Assets0.110.07510.1082
Very volatile
Graham Number10.129.648.7251
Slightly volatile
Operating Cycle166265253
Slightly volatile
Price Book Value Ratio3.753.951910.1663
Slightly volatile
Days Of Payables Outstanding31.5950.927149.6645
Pretty Stable
Company Equity Multiplier4.794.56312.5371
Very volatile
Long Term Debt To Capitalization0.140.24120.3051
Pretty Stable
Total Debt To Capitalization0.170.25530.1825
Pretty Stable
Debt Equity Ratio0.290.34280.3565
Pretty Stable
Quick Ratio2.584.55894.1973
Pretty Stable
Cash Ratio3.112.96062.5003
Slightly volatile
Cash Conversion Cycle134214204
Slightly volatile
Days Of Inventory Outstanding116147170
Pretty Stable
Days Of Sales Outstanding12311787.8295
Slightly volatile
Price To Book Ratio3.753.951910.1663
Slightly volatile
Fixed Asset Turnover6.197.13894.9458
Slightly volatile
Debt Ratio0.110.07510.1082
Very volatile
Price Sales Ratio1.111.16745.3074
Pretty Stable
Asset Turnover1.240.74180.848
Slightly volatile
Gross Profit Margin0.380.61040.5204
Slightly volatile
Price Fair Value3.753.951910.1663
Slightly volatile

Apyx Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap66.7 M103 M105.3 M
Pretty Stable
Enterprise Value66.4 M100.9 M103.3 M
Pretty Stable

Apyx Fundamental Market Drivers

Cash And Short Term Investments31.7 M

Apyx Upcoming Events

21st of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Apyx Medical Financial Statements

Apyx Medical investors use historical fundamental indicators, such as Apyx Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Apyx Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue439.2 K417.2 K
Total Revenue48.1 M27.1 M
Cost Of Revenue18.7 M13.4 M
Stock Based Compensation To Revenue 0.08  0.05 
Sales General And Administrative To Revenue 0.84  0.57 
Research And Ddevelopement To Revenue 0.11  0.11 
Capex To Revenue 0.02  0.01 
Revenue Per Share 1.35  0.98 
Ebit Per Revenue(0.39)(0.37)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CRMSalesforce
CRMSalesforce

Additional Tools for Apyx Stock Analysis

When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY